Medical Staff Pulse Newsletter

Dabigatran (Pradaxa) safety update

Pharmacy Focus

A safety update, reversal guidelines and a fact sheet regarding the anticoagulant dabigatran (Pradaxa®) were released recently.

» Read more

Meetings and events

Grand rounds

Click here to view upcoming Grand Rounds.

Upcoming CME conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - February 2012 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Proposals sought for $1.5M prostate cancer research grant

A request for letters of intent and proposals has been issued for the 2012 Team Science Award from the Steven Spielberg Discovery Fund in Prostate Cancer Research. Letters are due March 30.

The fund, established by a gift to the Samuel Oschin Comprehensive Cancer Institute, aims to support and encourage interdisciplinary collaboration and stimulate new therapeutic ideas in prostate cancer research and clinical care. The award is intended to bring together experts from multiple disciplines to create a personalized oncology approach to prostate cancer integrating molecular pathology, laboratory-based research, imaging (where appropriate), experimental therapeutics and genetics.

Priority will be given to proposals that bridge existing or planned SOCCI Developmental Programs; demonstrate promise of strengthening an expected P-30 grant; and lead to additional peer-reviewed funding. The team selected will be awarded a grant of $1.5 million spread over a period of three years. In order to qualify, a PI must hold an MD or PhD and SOCCI membership.

A letter of intent is required prior to full proposal submission. It should be sent electronically or hard copy to Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute.

2012 Team Science Award (PDF)